New automated method for identification of lung nodules in community-based settings

NewsGuard 100/100 Score

Pulmonary nodules are common, but few studies of lung nodule identification and clinical evaluation have been performed in community settings. Researchers from Kaiser Permanente Southern California identified 7,112 patients who had one or more nodules by using existing information within the electronic medical record.

Their study presented in the August 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed how researchers developed and implemented a new method for identifying lung nodules in community-based settings.

The researchers used a combination of ICD-9 codes, CPT codes and an algorithm for natural language processing (NLP) to classify the nodules. This automated method had a 96 percent sensitivity and 86 percent specificity compared to clinician review.

The authors suggest that the automated process, "could be used to study the incidence and prevalence of lung nodules in large popula-tions, with the caveat that approximately 13 percent of cases identi-fied by the automated method would not meet our definition of one or more nodules (e.g., be false-positives)."

Since this study favored sensitivity over specificity, the authors advise that the method "could be used as a sensitive first step to be followed by more specific review of radiology transcripts or actual imaging studies."

As screening programs for lung cancer have proven to be beneficial in specific high-risk populations, this study also provides useful information for the study of screen-detected nodules. 

Source: International Association for the Study of Lung Cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers